ArticleNeurosurgical review2025
Development and validation of a multi-parameter nomogram for venous thromboembolism in patients undergoing surgery for brain tumors: a retrospective analysis.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Venous thromboembolism (VTE) is a serious complication in patients undergoing brain tumor surgery, particularly those requiring neurological intensive care unit (NICU) monitoring. Risk factors for VTE vary among tumor types, and effective early warning tools remain scarce. This study aimed to develop a nomogram-based clinical prediction model to identify independent risk factors for postoperative VTE in brain tumor patients. A total of 400 NICU patients (aged 18-82 years; mean age 52.5 ± 15.6 years; 46.5% male) from January 2018 to July 2023 who underwent brain tumor surgery were included, among whom 96 developed postoperative VTE (24%). Univariate, LASSO regression, and multivariate logistic regression analyses identified independent predictors, and a nomogram prediction model was constructed. The C-index and calibration curve evaluated the model's discriminative ability and stability, while decision curve analysis assessed its clinical utility. The Linear Support Vector Machine (LSVM) method validated the model's robustness. Seven independent predictors were identified and incorporated into a nomogram: elevated preoperative D-dimer levels, elevated HbA1c levels post-admission, longer surgery duration, increased TT4 levels upon admission, increased BMI, older age and hyperlipidemia history. These factors were incorporated into a nomogram risk prediction model with an AUC of 0.937 using multivariate logistic regression. The calibration curve verified the model's stability, the C-index demonstrated strong discriminative ability, and decision curve analysis confirmed its clinical value. A linear support vector machine (LSVM) was further used to validate the predictive efficacy of the same set of variables achieved an overall accuracy of 85%. The nomogram integrates multiple clinical parameters to enhance the prediction and identification of VTE risk following brain tumor surgery. It demonstrated excellent discriminative ability, stability, and clinical applicability.
Indexed as
Identifiers
41117840What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.